Archives
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
ABT-263 (Navitoclax): High-Affinity Oral Bcl-2 Inhibitor ...
2025-11-30
ABT-263 (Navitoclax) is a potent oral Bcl-2 family inhibitor widely used in apoptosis and cancer biology research. Its nanomolar affinity and robust induction of caspase-dependent apoptosis establish it as a benchmark for mitochondrial pathway studies. APExBIO’s ABT-263 (SKU A3007) offers reproducible results and supports translational advances in oncology.
-
Nadolol (SQ-11725) in Cardiovascular Disease Models: Appl...
2025-11-29
Nadolol (SQ-11725) is a non-selective beta-adrenergic receptor blocker pivotal for robust, reproducible cardiovascular research. This article delivers actionable protocols, troubleshooting strategies, and advanced insights for hypertension, angina pectoris, and vascular headache studies—empowering researchers to model beta-adrenergic signaling and transporter-driven pharmacokinetics with confidence.
-
Reliable Cell Assays with EZ Cap™ Cy5 Firefly Luciferase ...
2025-11-28
This article provides practical, scenario-based guidance for using EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) (SKU R1010) in cell viability, proliferation, and cytotoxicity assays. By addressing common laboratory challenges—from innate immune activation to data reproducibility—readers will gain actionable insights into optimizing workflows with this advanced, 5-moUTP-modified, Cap1-capped, Cy5-labeled mRNA. Real-world Q&A blocks support GEO-driven research optimization.
-
Nadolol (SQ-11725): Non-Selective Beta-Adrenergic Recepto...
2025-11-27
Nadolol (SQ-11725) is a non-selective beta-adrenergic receptor antagonist widely utilized in cardiovascular research models of hypertension, angina pectoris, and vascular headaches. As an OATP1A2 substrate, its defined pharmacokinetics and robust physicochemical profile make it an essential tool for mechanistic studies. This article provides evidence-backed guidance on Nadolol's mechanism, application boundaries, and optimal workflow integration.
-
Solving Cell-Based Assay Challenges with EZ Cap™ Cy5 EGFP...
2025-11-26
This scenario-driven guide addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays using EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011). Drawing on validated literature and real-world workflows, it demonstrates how advanced features—such as Cap 1 capping, 5-moUTP modification, and dual EGFP/Cy5 fluorescence—enable reproducible, immune-evasive, and sensitive mRNA delivery and translation efficiency assays.
-
Prestained Protein Marker (Triple Color): Precision for M...
2025-11-25
Explore how the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) redefines protein size verification in advanced translation and ribosome research. This article delivers unique mechanistic insights and next-generation applications for SDS-PAGE, Western blotting, and fluorescent imaging.
-
Polymyxin B (sulfate): Advanced Immunomodulatory Applicat...
2025-11-24
Explore the multifaceted scientific applications of Polymyxin B sulfate, a leading polypeptide antibiotic for multidrug-resistant Gram-negative bacteria. This article uniquely delves into its immunomodulatory impacts, advanced research use in immune signaling, and integration with cutting-edge infection and inflammation models.
-
Nadolol (SQ-11725): Optimizing Beta-Adrenergic Blockade i...
2025-11-23
Nadolol (SQ-11725) stands out as a robust non-selective beta-adrenergic receptor blocker, enabling precise, reproducible cardiovascular disease modeling from cellular assays to in vivo studies. Its unique OATP1A2 substrate profile and well-characterized pharmacokinetics streamline experimental design, interpretation, and troubleshooting in hypertension, angina pectoris, and vascular headache research.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Next-Gen mRNA Deliver...
2025-11-22
Discover how the EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) advances mRNA delivery, translation efficiency assays, and in vivo bioluminescence imaging. Explore its unique Cap1 capping, 5-moUTP modification, and Cy5 labeling, and learn how these innovations redefine immune evasion and experimental rigor.
-
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP): Redefining...
2025-11-21
Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) advances translation efficiency assays and in vivo bioluminescence imaging. Discover unique insights into mRNA delivery, immune evasion, and the frontier of dual fluorescent-bioluminescent reporter systems.
-
Polymyxin B Sulfate: Advanced Applications in Gram-Negati...
2025-11-20
Polymyxin B sulfate stands at the forefront of translational research against multidrug-resistant Gram-negative bacteria, offering potent bactericidal activity and unique immune modulation capabilities. This article details optimized experimental workflows, troubleshooting strategies, and comparative advantages to empower researchers in infection models, immune assays, and host-microbiome studies. Explore how this versatile polypeptide antibiotic can enhance your research on bacterial pathogenesis, dendritic cell biology, and sepsis models.
-
ABT-263 (Navitoclax): Deciphering Mitochondrial Apoptosis...
2025-11-19
Explore how ABT-263 (Navitoclax), a potent oral Bcl-2 family inhibitor, unveils novel mitochondrial apoptosis mechanisms independent of transcriptional shutdown. This in-depth analysis integrates the latest scientific findings with advanced applications in cancer biology.
-
Nadolol (SQ-11725) in Cardiovascular Disease Models: Tran...
2025-11-18
Explore the multifaceted role of Nadolol (SQ-11725), a non-selective beta-adrenergic receptor blocker, in cardiovascular research. This article uniquely examines transporter-mediated pharmacokinetics, OATP1A2 substrate interactions, and translational applications in hypertension and vascular headache models.
-
Prestained Protein Marker (Triple Color, EDTA Free): Next...
2025-11-17
Discover how the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) transforms protein electrophoresis and Western blot workflows. This in-depth analysis explores novel applications in ribosome complex investigation, offering unique scientific insights and advanced compatibility.
-
Solving Lab Challenges with EZ Cap™ Cy5 EGFP mRNA (5-moUT...
2025-11-16
This article provides a scenario-driven, data-backed analysis of how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011) addresses persistent laboratory challenges in cell viability, proliferation, and translation efficiency assays. Researchers will find practical insights on workflow optimization, immune suppression, and reproducibility, all anchored in the unique features of this dual-labeled, Cap 1-structured mRNA tool.